Introduction:Diagnosing non-small cell lung cancer on biopsy/cellblock samples by morphology may be demanding. As sparing material for molecular testing is mandatory, a minimalist immunohistochemistry (IHC)-based diagnostic approach is warranted by means of novel, reliable, and easy-to-assess biomarkers.Methods:Forty-six consecutive biopsy/cellblock samples and the corresponding resection specimens (as the gold standard for morphology and IHC) from 30 adenocarcinomas (AD), 10 squamous carcinomas (SQC), 5 adenosquamous carcinomas (ADSQC), and 1 sarcomatoid carcinoma (SC) were IHC-evaluated for p40 [corresponding to nontransactivating ΔNp63 isoforms] and thyroid transcription factor-1 (TTF1) by semiquantitative assessment. For p40, also immun...
OBJECTIVES: Advancements in non-small cell lung cancer treatment based on targeted therapies have ma...
Background : There are limitations of histomorphology in the appropriate categorization of lung car...
Whether non-small cell lung carcinoma (NSCLC) unveiled by immunohistochemistry (IHC) has the same cl...
Introduction:Diagnosing non-small cell lung cancer on biopsy/cellblock samples by morphology may be ...
Introduction: Diagnosing non-small cell lung cancer on biopsy/cellblock samples by morphology may be...
Introduction:More detailed typing of non-small cell lung cancer on small biopsy specimens is increas...
Introduction: Diagnosing Non-Small Cell Lung Carcinoma (NSCLC) by morphology on small biopsy specim...
Background & objectives: Accurate histopathological subtyping of non-small cell lung carcinoma (NSCL...
INTRODUCTION: More detailed typing of non-small cell lung cancer on small biopsy specimens is increa...
BackgroundThere is growing evidence that lung adenocarcinoma and squamous cell carcinoma (SQCC) have...
AbstractPurposeEvaluation of the value of thyroid transcription factor (TTF-1) and P63 in subtyping ...
IntroductionThe emergence of treatments for non-small cell lung carcinoma (NSCLC) with differential ...
This chapter is a combination of personal experience of a pulmonary pathologist and available refere...
© The Author(s) 2020. Background: Histologic subtyping of lung cancer has significant implications f...
BackgroundA single platform designed for the synchronous screening of multiple mutations can potenti...
OBJECTIVES: Advancements in non-small cell lung cancer treatment based on targeted therapies have ma...
Background : There are limitations of histomorphology in the appropriate categorization of lung car...
Whether non-small cell lung carcinoma (NSCLC) unveiled by immunohistochemistry (IHC) has the same cl...
Introduction:Diagnosing non-small cell lung cancer on biopsy/cellblock samples by morphology may be ...
Introduction: Diagnosing non-small cell lung cancer on biopsy/cellblock samples by morphology may be...
Introduction:More detailed typing of non-small cell lung cancer on small biopsy specimens is increas...
Introduction: Diagnosing Non-Small Cell Lung Carcinoma (NSCLC) by morphology on small biopsy specim...
Background & objectives: Accurate histopathological subtyping of non-small cell lung carcinoma (NSCL...
INTRODUCTION: More detailed typing of non-small cell lung cancer on small biopsy specimens is increa...
BackgroundThere is growing evidence that lung adenocarcinoma and squamous cell carcinoma (SQCC) have...
AbstractPurposeEvaluation of the value of thyroid transcription factor (TTF-1) and P63 in subtyping ...
IntroductionThe emergence of treatments for non-small cell lung carcinoma (NSCLC) with differential ...
This chapter is a combination of personal experience of a pulmonary pathologist and available refere...
© The Author(s) 2020. Background: Histologic subtyping of lung cancer has significant implications f...
BackgroundA single platform designed for the synchronous screening of multiple mutations can potenti...
OBJECTIVES: Advancements in non-small cell lung cancer treatment based on targeted therapies have ma...
Background : There are limitations of histomorphology in the appropriate categorization of lung car...
Whether non-small cell lung carcinoma (NSCLC) unveiled by immunohistochemistry (IHC) has the same cl...